Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 16 de 16
Filtrar
1.
Eur J Vasc Endovasc Surg ; 53(3): 439-442, 2017 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-28139409

RESUMEN

OBJECTIVE: The aim of this study was to compare the levels of acetyl-dimethylarginine (ADMA), symmetric dimethylarginine (SDMA), and the l-arginine/ADMA ratio before and after iloprost treatment in patients with Buerger's disease. METHODS: Between January 2011 and December 2015, data from 44 patients (36 males, 8 females, mean age 48.7 ± 18.1 years) with the diagnosis of Fontaine Stage III-IV Buerger's disease were included. Iloprost infusion was administered intravenously through the forearm veins for 7 days at a dose of 0.5-1.5 ng/kg/min over 16 h. Blood samples were collected before and after treatment for measurement of ADMA, SDMA, and l-arginine. ADMA, SDMA, l-arginine levels were measured using high performance liquid chromatography (HPLC). RESULTS: After iloprost treatment, ADMA and SDMA levels significantly decreased (p = .001). The increase in the l-arginine levels was not significant (p = .16). However, the l-arginine/ADMA ratio increased significantly (p = .001). CONCLUSION: Iloprost treatment decreases ADMA and SDMA, which are associated with endothelial dysfunctions in patients with Buerger's disease. Of note, the still higher than normal range of SDMA levels after iloprost treatment suggests that treatment should continue until SDMA levels are within the normal range in this patient population.


Asunto(s)
Arginina/análogos & derivados , Iloprost/administración & dosificación , Tromboangitis Obliterante/tratamiento farmacológico , Vasodilatadores/administración & dosificación , Adulto , Anciano , Arginina/sangre , Biomarcadores/sangre , Femenino , Humanos , Infusiones Intravenosas , Masculino , Persona de Mediana Edad , Tromboangitis Obliterante/sangre , Tromboangitis Obliterante/diagnóstico , Factores de Tiempo , Resultado del Tratamiento
2.
Biotech Histochem ; 91(2): 128-36, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-26720589

RESUMEN

Prolactinoma is the most common pituitary tumor. Most pituitary tumors are benign, but they often are clinically significant. We investigated cytokinesis-block micronucleus cytome (CBMN cyt) assay parameters and oxidative DNA damage in patients with prolactinoma to assess the relations among age, prolactin level, pituitary adenoma diameter and 8-hydroxy-2'-deoxyguanosine (8-OHdG) level in patients with prolactinoma. We investigated 27 patients diagnosed with prolactinoma and 20 age- and sex-matched healthy controls. We measured CBMN cyt parameters and plasma 8-OHdG levels in peripheral blood lymphocytes of patients with prolactinoma and controls. The frequencies of micronucleus (MN), nucleoplasmic bridge, nuclear bud, apoptotic and necrotic cells, and plasma 8-OHdG levels in patients with prolactinoma were significantly greater than controls. MN frequency was correlated positively with age, prolactin levels and pituitary adenoma diameters in patients with prolactinoma. The increased chromosomal and oxidative DNA damage, and the positive correlation between MN frequency, prolactin levels and pituitary adenoma diameters may be associated with increased risk of cancer in patients with prolactinoma, because increased MN frequency is a predictor of cancer risk.


Asunto(s)
Citocinesis/fisiología , Linfocitos/metabolismo , Estrés Oxidativo , Neoplasias Hipofisarias/metabolismo , Prolactina/metabolismo , Prolactinoma/metabolismo , Adolescente , Adulto , Núcleo Celular/metabolismo , Daño del ADN/efectos de los fármacos , Femenino , Humanos , Masculino , Pruebas de Micronúcleos , Persona de Mediana Edad , Necrosis/patología , Estrés Oxidativo/fisiología , Adulto Joven
3.
Clin Microbiol Infect ; 21(11): 1008.e9-1008.e18, 2015 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-26232534

RESUMEN

We aimed to describe clinical, laboratory, diagnostic and therapeutic features of spinal tuberculosis (ST), also known as Pott disease. A total of 314 patients with ST from 35 centres in Turkey, Egypt, Albania and Greece were included. Median duration from initial symptoms to the time of diagnosis was 78 days. The most common complications presented before diagnosis were abscesses (69%), neurologic deficits (40%), spinal instability (21%) and spinal deformity (16%). Lumbar (56%), thoracic (49%) and thoracolumbar (13%) vertebrae were the most commonly involved sites of infection. Although 51% of the patients had multiple levels of vertebral involvement, 8% had noncontiguous involvement of multiple vertebral bodies. The causative agent was identified in 41% of cases. Histopathologic examination was performed in 200 patients (64%), and 74% were consistent with tuberculosis. Medical treatment alone was implemented in 103 patients (33%), while 211 patients (67%) underwent diagnostic and/or therapeutic surgical intervention. Ten percent of the patients required more than one surgical intervention. Mortality occurred in 7 patients (2%), and 77 (25%) developed sequelae. The distribution of the posttreatment sequelae were as follows: 11% kyphosis, 6% Gibbus deformity, 5% scoliosis, 5% paraparesis, 5% paraplegia and 4% loss of sensation. Older age, presence of neurologic deficit and spinal deformity were predictors of unfavourable outcome. ST results in significant morbidity as a result of its insidious course and delayed diagnosis because of diagnostic and therapeutic challenges. ST should be considered in the differential diagnosis of patients with vertebral osteomyelitis, especially in tuberculosis-endemic regions. Early establishment of definitive aetiologic diagnosis and appropriate treatment are of paramount importance to prevent development of sequelae.


Asunto(s)
Tuberculosis de la Columna Vertebral/epidemiología , Tuberculosis de la Columna Vertebral/patología , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Antituberculosos/administración & dosificación , Enfermedades Endémicas , Femenino , Humanos , Cooperación Internacional , Masculino , Región Mediterránea/epidemiología , Persona de Mediana Edad , Estudios Retrospectivos , Procedimientos Quirúrgicos Operativos , Análisis de Supervivencia , Resultado del Tratamiento , Tuberculosis de la Columna Vertebral/tratamiento farmacológico , Tuberculosis de la Columna Vertebral/cirugía , Adulto Joven
4.
Eur Rev Med Pharmacol Sci ; 19(10): 1907-14, 2015 May.
Artículo en Inglés | MEDLINE | ID: mdl-26044239

RESUMEN

OBJECTIVE: Intestinal obstruction (IO) is a disease which generates approximately 20% of emergency surgery and tends to with high mortality. Prevention of oxidative stress, bacterial translocation and tissue damage caused by IO is an important medical issue. Caffeic acid phenethyl ester (CAPE) is an anti-inflammatory, antioxidant, anti-bacterial and immunomodulatory agent. In this experimental study, we aimed to investigate the effects of CAPE on bacterial translocation, inflammatory response, oxidative stress and tissue injury caused by intestinal obstruction in a rat model. MATERIALS AND METHODS: Breafly, thirty Wistar albino rats divided into three groups as Sham (n=10), IO (n=10) and IO + CAPE (10 µmol/kg day, intraperitoneal) (n=10). The tissues from the study groups were examined biochemically, microbiologically and histopathologically. RESULTS: In CAPE treated group, decreased serum levels of proinflammatory cytokines (TNF-α, IL-6, IL-1ß) and CRP (p < 0.05), additionally increased serum levels of antioxidant parameters (PONS, TAS) (p < 0.05), were observed after IO. Microbiologically, the rates of positive cultures of the lymph node, spleen, liver and blood were significantly decreased in CAPE treated group compared to the IO group. Also histopathological examination showed that the intestinal mucosal injury score and hepatic portal inflammation score were significantly decreased in the CAPE treated group (p < 0.05). CONCLUSIONS: It is suggested that intraperitoneal administration of CAPE might has potential antibacterial, anti-inflammatory, antioxidant and immunomodulatory effects in IO. So, further studies on IO are needed to evaluate exact antibacterial, antiinflammatory, antioxidant and immunomodulatory effects of CAPE.


Asunto(s)
Traslocación Bacteriana/efectos de los fármacos , Ácidos Cafeicos/administración & dosificación , Modelos Animales de Enfermedad , Mediadores de Inflamación/antagonistas & inhibidores , Obstrucción Intestinal/tratamiento farmacológico , Alcohol Feniletílico/análogos & derivados , Animales , Antiinflamatorios/farmacología , Antiinflamatorios/uso terapéutico , Traslocación Bacteriana/inmunología , Mediadores de Inflamación/inmunología , Inyecciones Intraperitoneales , Mucosa Intestinal/efectos de los fármacos , Mucosa Intestinal/inmunología , Mucosa Intestinal/microbiología , Obstrucción Intestinal/inmunología , Obstrucción Intestinal/microbiología , Estrés Oxidativo/efectos de los fármacos , Estrés Oxidativo/inmunología , Alcohol Feniletílico/administración & dosificación , Ratas , Ratas Wistar
6.
Eur Rev Med Pharmacol Sci ; 18(4): 471-6, 2014.
Artículo en Inglés | MEDLINE | ID: mdl-24610612

RESUMEN

AIM: Malathion is one of the most widely used organophosphate pesticides and herbicides. It has given rise to major clinical problems by its poisoning in all over the world. Malathion also a highly lipophilic agent, and tends to accumulate within lipid-rich tissue like a brain in the body, causing toxicity. Therefore, the study was aimed to investigate if there is a possible beneficial effect of using intralipid fat emulsion (IFE) on the neurotoxicity, and to detect it time-dependently at the beginning, 6th and 12th hours of M intoxication. MATERIALS AND METHODS: Forty-eight rats were randomly divided into six groups including: control (C), Lipid (L) group (18.6 mL/kg oral IFE), Malathion (M) group (10 mg/kg oral M), M0L group (IFE treated after immediate from M), M6L group (IFE treated after 6 hours from M), M12L group (IFE treated after 12 hours from M). RESULTS: M group in comparison with all others group, there was an increase in the total oxidant status (TOS) level. M group in comparison with C, L, M0L groups, it was seen significantly decrease in the total antioxidant capacity (TAC) level. Interestingly, M group in comparison with M6L and M12L groups, there was no significant difference among these groups in terms of the TAC levels. Although there was no significant difference among C, L and M0L groups in terms of both TAC and TOS levels, but was significant difference C, L groups in comparison with M6L, M12L groups in terms of TAC levels. C group in comparison with L, M0L, M6L, M12L groups in terms of TOS levels, there was no significant difference. These findings have indicated that IFE seriously reduced TOS levels in all the groups depending on time. Also, M0L group in comparison with M6L and M12L groups, there was significantly increase of the TAC levels. There was no statistically significant difference between M6L and M12L groups. These biochemical results were confirmed with immunohistochemical results. CONCLUSIONS: The study has had some certain evidence that IFE is a promising safe therapy for acutely intoxicated cases by organophosphate. It is much more effective if used at the beginning of organophosphate poisoning. As such, there is no need to avoid using IFE in clinical practice.


Asunto(s)
Antioxidantes/farmacología , Insecticidas , Malatión , Neuronas/efectos de los fármacos , Fármacos Neuroprotectores/farmacología , Síndromes de Neurotoxicidad/tratamiento farmacológico , Intoxicación por Organofosfatos/prevención & control , Fosfolípidos/farmacología , Aceite de Soja/farmacología , Animales , Citoprotección , Modelos Animales de Enfermedad , Emulsiones/farmacología , Masculino , Neuronas/metabolismo , Neuronas/patología , Síndromes de Neurotoxicidad/etiología , Síndromes de Neurotoxicidad/metabolismo , Síndromes de Neurotoxicidad/patología , Intoxicación por Organofosfatos/etiología , Intoxicación por Organofosfatos/metabolismo , Intoxicación por Organofosfatos/patología , Estrés Oxidativo/efectos de los fármacos , Ratas Wistar , Factores de Tiempo
7.
Artículo en Inglés | MEDLINE | ID: mdl-22036315

RESUMEN

This study reports the optimized molecular structures, vibrational frequencies including Infrared intensities and Raman activities, corresponding vibrational assignments, (1)H and (13)C NMR chemical shifts, the magnitudes of the JCH and JCC coupling constants, Ultraviolet-visible (UV-vis) spectra, thermodynamic properties and atomic charges of the title compounds, α,α,α-trifluoro-3, -p and o-nitrotoluene, in the ground state by means of the density functional theory (DFT) with the standard B3LYP/6-311++G(d,p) method and basis set combination for the first time. Theoretical vibrational spectra were interpreted by normal coordinate analysis based on scaled density functional force field. The results show that the vibrational frequencies and chemical shifts calculated were obtained to be in good agreement with the experimental data. Based on the comparison between experimental results and theoretical data, the calculation level chosen is powerful approach for understanding the identification of all the molecules studied. In addition, not only were frontier molecular orbitals (HOMO and LUMO), molecular electrostatic potential (MEP) and electrostatic potential (ESP) simulated but also the dipole moment, softness, electronegativity, chemical hardness, electrophilicity index, transition state and energy band gap values were predicted. According to the investigations, all compounds were found to be useful to bond metallically and interact intermolecularly; however, the thermodynamic properties confirm that the α,α,α-trifluoro-p-nitrotoluene was more reactive and more polar than the others.


Asunto(s)
Tolueno/análogos & derivados , Halogenación , Espectroscopía de Resonancia Magnética , Modelos Moleculares , Teoría Cuántica , Espectrofotometría Ultravioleta , Electricidad Estática , Tolueno/química
8.
J Chemother ; 22(5): 355-7, 2010 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-21123160

RESUMEN

The aim of this observational prospective study was to compare the effect of fosfomycin tromethanol (FT) and carbapenems (meropenem or imipenem cilastatin) in the treatment of extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli-related complicated lower urinary tract infection (CLUTI). Inclusion criteria were: patients who were aged >18 yr with dysuria or problems with frequency or urgency in passing urine; those with >20 leukocytes/mm³ in urine microscopy and culture-proven ESBL-producing carbapenem or FT-sensitive E. coli in the urine (>105 cfu/mm³); no leukocytosis or fever; and who were treated with ft (oral 3 g sachet x 1 every other night, three times) or carbapenems between march 2005 and January 2006 in our outpatient clinic and hospital. A total of 47 CLUTI attacks in 47 patients (27 FT group, 20 carbapenem group) were observed prospectively. Clinical and microbiological success in the carbapenem and ft groups was similar (19/20 vs 21/27 and 16/20 vs 16/27 p>0.05). Drug acquisition costs were significantly lower in the FT group (p<0.001). Although it is not a randomized controlled study, these data show that ft may be a suitable, effective and cheap alternative in the treatment of ESBL-producing E. coli-related CLUTI.


Asunto(s)
Antibacterianos/uso terapéutico , Carbapenémicos/uso terapéutico , Infecciones por Escherichia coli/tratamiento farmacológico , Escherichia coli/efectos de los fármacos , Fosfomicina/uso terapéutico , Infecciones Urinarias/tratamiento farmacológico , beta-Lactamasas/metabolismo , Adulto , Anciano , Anciano de 80 o más Años , Carbapenémicos/economía , Farmacorresistencia Bacteriana , Escherichia coli/enzimología , Infecciones por Escherichia coli/microbiología , Femenino , Fosfomicina/economía , Humanos , Masculino , Pruebas de Sensibilidad Microbiana , Persona de Mediana Edad , Estudios Prospectivos , Infecciones Urinarias/microbiología , Adulto Joven
9.
Methods Find Exp Clin Pharmacol ; 29(1): 47-52, 2007.
Artículo en Inglés | MEDLINE | ID: mdl-17344944

RESUMEN

Appetite suppression is one of the most common side effects of methylphenidate (MPH), which is used for treatment of attention-deficit hyperactivity disorder (ADHD). Relation of appetite and leptin is well known but there is no report regarding MPH use and leptin. In this study we compared the baseline leptin levels of ADHD children with the controls and studied the interaction between MPH and leptin-insulin level in ADHD children under MPH treatment. The major finding of this study is that at a total daily dose of 0.6 mg/kg short-acting MPH treatment, one does not observe significant side effects related to appetite suppression and metabolic features as measured via body mass index, insulin and leptin levels. Thus this range seems to be safe in developing ADHD children with minimum side effects regarding appetite for short-term treatment.


Asunto(s)
Apetito/efectos de los fármacos , Trastorno por Déficit de Atención con Hiperactividad/tratamiento farmacológico , Estimulantes del Sistema Nervioso Central/efectos adversos , Insulina/sangre , Leptina/metabolismo , Metilfenidato/efectos adversos , Índice de Masa Corporal , Estimulantes del Sistema Nervioso Central/farmacología , Estimulantes del Sistema Nervioso Central/uso terapéutico , Niño , Humanos , Masculino , Metilfenidato/farmacología , Metilfenidato/uso terapéutico
10.
Infection ; 31(6): 387-91, 2003 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-14735380

RESUMEN

BACKGROUND: Tuberculosis is still a major cause of serious illness in developing countries. The objective of this study was to assess the clinical, laboratory, radiological and prognostic features of tuberculous meningitis (TBM) in immuncompetent adult patients. PATIENTS AND METHODS: Sixty-one patients with confirmed or presumed TBM seen over a 12-year period at the Neurology Department of Bakirköy Research and Training Hospital for Psychiatric and Neurological Disease, Istanbul, Turkey, were analyzed retrospectively. Patients were grouped according to the severity of meningitis on admission (stages I, II and III). They were also divided into two groups according to the presence of paradoxical response (progressive increase of lymphocytes or increase of polymorphonuclear cells instead of lymphocytes) in CSF samples. A combination of five antituberculosis drugs was used in the 1st month of treatment. Patients received antituberculosis therapy for at least 12 months. The outcome of the patients was defined on the basis of the 12-month Barthel index (BI) score (BI < 12 poor; BI >/= 12 good). For statistical analysis death was included in the poor outcome group. RESULTS: Paradoxical response in CSF findings was seen in 20 patients. There was no statistically significant difference between the outcome of the patients with and without CSF paradoxical response; however, new tuberculomas developed more frequently in the first group (p < 0.05). The overall mortality was 27.8%. Stage of disease was found to be independently associated with the 12-month outcome (OR 7.2; 95% CI 1.7-30.3, p = 0.007). CONCLUSION: In developing countries such as Turkey, tuberculosis is still an important public health issue. Early suspicion and appropriate long-term antituberculosis therapy together with corticosteroids may reduce mortality and morbidity in TBM patients.


Asunto(s)
Mycobacterium tuberculosis/aislamiento & purificación , Tuberculosis Meníngea/diagnóstico , Tuberculosis Meníngea/epidemiología , Adolescente , Adulto , Distribución por Edad , Anciano , Antituberculosos/uso terapéutico , Intervalos de Confianza , Femenino , Humanos , Incidencia , Masculino , Persona de Mediana Edad , Oportunidad Relativa , Probabilidad , Estudios Retrospectivos , Medición de Riesgo , Índice de Severidad de la Enfermedad , Distribución por Sexo , Tasa de Supervivencia , Tomografía Computarizada por Rayos X , Tuberculosis Meníngea/tratamiento farmacológico , Turquía/epidemiología
11.
Dev Med Child Neurol ; 43(11): 755-60, 2001 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-11730150

RESUMEN

The purpose of this study was to estimate striatal dopamine (D2) receptor availability in non-drug treated children with attention-deficit-hyperactivity disorder (ADHD) before and after methylphenidate therapy, and to examine correlations between severity of symptoms and response rates to stimulant medication with levels of striatal D2 receptor binding. Nine children (six males, three females; mean age 9.8 years, SD 2.3 years) with ADHD participated. All underwent iodobenzamide (123I IBZM) brain SPECT within 2 hours following intravenous injection of 123I IBZM before and 3 months after methylphenidate therapy. A semiquantitative approach was used to generate indices of specific D2 receptor binding in the basal ganglia. Specific binding ratios at baseline were higher than the previously reported specific binding values obtained in studies using young healthy adults. D2 availability reduced significantly (paired t-test,p<0.05) as a function of methylphenidate therapy in patients with ADHD in all four regions of the striatum. When the relation between therapy response and D2 availability was investigated, we observed that the higher the baseline D2 levels were, the higher the response rate was (detected as the percentage reduction of hyperactivity scores and Conners Teacher Rating Scale scores), while no such trend was observed between the initial D2 binding levels and the response in attention-deficit scores. Results indicate that in non-drug treated children with ADHD, higher D2 receptor availability is observed at baseline which is down-regulated back to reported near-normal values after methylphenidate therapy. The effect of methylphenidate on D2 receptor levels in patients with ADHD is similar to that observed in healthy adults; a down-regulation phenomenon within 0 to 30%. In addition, initially higher values of D2 availability seem to indicate better response to methylphenidate therapy in ADHD.


Asunto(s)
Trastorno por Déficit de Atención con Hiperactividad/metabolismo , Receptores de Dopamina D2/metabolismo , Adolescente , Trastorno por Déficit de Atención con Hiperactividad/diagnóstico , Trastorno por Déficit de Atención con Hiperactividad/tratamiento farmacológico , Núcleo Caudado/metabolismo , Estimulantes del Sistema Nervioso Central/uso terapéutico , Niño , Cuerpo Estriado/metabolismo , Electroencefalografía , Femenino , Humanos , Yodobencenos/farmacocinética , Masculino , Metilfenidato/uso terapéutico , Putamen/metabolismo , Radiofármacos/farmacocinética , Índice de Severidad de la Enfermedad , Tomografía Computarizada de Emisión de Fotón Único
12.
Turk J Pediatr ; 43(3): 231-6, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11592515

RESUMEN

Diagnosis of attention-deficit and disruptive behavior disorders defines a group of disorders which have common properties. This group consists of attention-deficit hyperactivity disorder, conduct disorder and oppositional defiant disorder. In order to differentiate these disorders, which share similar properties, it is important to verify the existing differences. In this respect, differences between and distribution of perinatal factors in these three disorders were investigated. The study was conducted in the Child Psychiatry and Pediatric Neurology Departments over a 20-month period. Two hundred and seventy children out of 1,556 attendant with various complaints were diagnosed to have one of the following disorders: 121 had attention-deficit hyperactivity disorder, 50 had oppositional defiant disorder and 99 had conduct disorder. The prenatal and perinatal data of the patients were evaluated retrospectively by a neonatologist. With regard to the investigated parameters, none showed any significant difference between the three groups when compared. The three disorders, which share many similarities in terms of the symptoms, also show similarities in terms of perinatal factors. Since we did not find any study similar in design, our results, although statistically not significant, are discussed in light of the little data available.


Asunto(s)
Asfixia Neonatal/complicaciones , Déficit de la Atención y Trastornos de Conducta Disruptiva/epidemiología , Parto Obstétrico , Recien Nacido Prematuro , Complicaciones del Embarazo , Adolescente , Déficit de la Atención y Trastornos de Conducta Disruptiva/diagnóstico , Déficit de la Atención y Trastornos de Conducta Disruptiva/etiología , Niño , Femenino , Humanos , Recién Nacido , Masculino , Embarazo , Estudios Retrospectivos , Factores de Riesgo , Turquía/epidemiología
13.
Eur J Hum Genet ; 9(1): 39-44, 2001 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-11175298

RESUMEN

Bipolar affective disorder (BPAD), also known as manic-depressive illness, is a common complex, polygenic disorder characterised by recurrent cyclic episodes of mania and depression. Family, twin, and adoption studies strongly suggest a genetic predisposition/susceptibility to BPAD, but no genes have yet been identified. We studied a large Turkish pedigree, with an apparently autosomal dominant BPAD, which contained 13 affected individuals. The age of onset ranged from 15-40 with a mean of 25 years. The phenotypes consisted of recurrent manic and major depressive episodes, including suicidal attempts; there was usually full remission with lithium treatment. A genome-wide linkage analysis using a dominant mode of inheritance showed strong evidence for a BPAD susceptibility locus on chromosome 20p11.2-q11.2. The highest 2-point lod score of 4.34 at theta = 0 was obtained with markers D20S604, D20S470, D20S836 and D20S838 using a dominant model with full penetrance. Haplotype analysis enabled the mapping of the BPAD locus in this family between markers D20S186 and D20S109, to a region of approximately 42 cM.


Asunto(s)
Trastorno Bipolar/genética , Cromosomas Humanos Par 20/genética , Genes Dominantes , Adulto , Anciano , Alelos , Trastorno Bipolar/patología , Bandeo Cromosómico , Mapeo Cromosómico , ADN/genética , Salud de la Familia , Femenino , Genotipo , Humanos , Escala de Lod , Masculino , Repeticiones de Microsatélite , Persona de Mediana Edad , Linaje , Penetrancia , Fenotipo , Turquía
14.
Soc Psychiatry Psychiatr Epidemiol ; 32(2): 109-12, 1997 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-9050353

RESUMEN

The present study aimed to investigate clinical, demographic and follow-up features of borderline personality disorder (BPD) in Turkey. Among 738 inpatients consecutively admitted to a university psychiatric clinic, we attempted to trace 75 patients diagnosed with BPD according to DSM-III-R criteria 2- to 4-years after their index discharge. Of 61 patients who could be traced, 2 had committed suicide and 45 were included in a follow-up study. A semi-structured interview confirmed the previous diagnosis in all but two patients. The mean Global Assessment Scale score of the follow-up sample showed a 13.4% increase during the follow-up interval. Affective disorders were concomitantly diagnosed in 76.7% of the BPD patients, and the lifetime prevalence rate for this diagnostic category was estimated at 100%. Substances abuse disorder emerged as the second common Axis I diagnosis. The data obtained in the present study were in agreement with findings of previous studies on BPD conducted mostly in Western countries.


Asunto(s)
Trastorno de Personalidad Limítrofe/complicaciones , Trastorno de Personalidad Limítrofe/diagnóstico , Adolescente , Adulto , Trastorno de Personalidad Limítrofe/psicología , Comorbilidad , Femenino , Estudios de Seguimiento , Humanos , Entrevista Psicológica , Masculino , Persona de Mediana Edad , Pronóstico , Estudios Retrospectivos , Turquía
15.
Surg Neurol ; 39(5): 377-9, 1993 May.
Artículo en Inglés | MEDLINE | ID: mdl-8493598

RESUMEN

Primary multiple hydatid cyst in the brain is uncommon. We report two large primary multiple hydatid cysts of the brain in an adult, which were removed without rupture by two separate operations.


Asunto(s)
Encefalopatías/cirugía , Equinococosis/cirugía , Adulto , Encefalopatías/diagnóstico por imagen , Equinococosis/diagnóstico por imagen , Humanos , Masculino , Radiografía
16.
Neurochirurgia (Stuttg) ; 35(6): 204-6, 1992 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-1494415

RESUMEN

In this report we present two families with von Hippel-Lindau syndrome. We operated on haemangioblastomas in two members, one from each, in our clinic. In the first family we saw 17 lesions in 9 members. Although in the first family carcinoma of the kidney was often observed, in the second family retinal haemangioma was found to be predominant, namely, in eight out of nine patients. In both families there were 11 patients with retinal haemangioma; of these, 9 patients were blind (82%). In 6 patients with retinal haemangioblastoma blindness was unilateral and bilateral only in one. All the patients with renal carcinoma were male and died young. In one of our patients with renal carcinoma we found metastatic lesions in the distal and proximal parts of the femur, vertebral arch, cranium and the thoracic wall. In these two families 23 members had 32 lesions, from which eleven were retinal haemangiomas (3 + 8), nine haemangioblastomas of CNS (5 + 4), one a renal cyst (0 + 1), eight renal carcinomas (7 + 1), two pancreatic cysts (1 + 1) and one liver cyst (0 + 1).


Asunto(s)
Enfermedad de von Hippel-Lindau/genética , Adulto , Cromosomas Humanos Par 3 , Femenino , Tamización de Portadores Genéticos , Humanos , Neoplasias Renales/diagnóstico , Neoplasias Renales/genética , Neoplasias Renales/mortalidad , Masculino , Linaje , Tasa de Supervivencia , Enfermedad de von Hippel-Lindau/diagnóstico , Enfermedad de von Hippel-Lindau/mortalidad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...